subscribe
A Rare Lysosomal Storage Disease
Contact: info@npcfund.org

Archive for the ‘Blog’ Category

Social Security Adds 38 New Medical Conditions that Qualify for Disability

Social Security adds 38 new medical conditions that qualify for disability help.  The new conditions range from early-onset Alzheimer’s disease to rare diseases that primarily affect children which includes Niemann-Pick Type C! Personally this seems like a relief for so many families. One of the goals of […]

Read more

UPDATE 2-US FDA panel backs new use for Actelion drug [Zavesca]

We’re a few weeks behind in updating this information but some big steps have happened recently regarding the potential FDA approval for Zavesca. The US Advisory panel on Jan. 12th recommended approval! This snippet is from the article on Reuters regarding the breaking news: Doctors can prescribe […]

Read more

Historic FDA related drug advisory committee will meet | Zavesca

This is an email from Nadine Hill of the NNPDF. This is good news. If the FDA does say lets move forward that means more families might be able to participate because the drug would be FDA approved. All though this isn’t a cure it is one […]

Read more

Today, there is no cure or effective treatment

The NPCF was formed to help create a entity that we could bring to communities that surround us the awareness needed to shed light on a disease that researchers are taking interest in. We felt after facing this reality that research has a different time line than parents yet they are making progress then why could we not help out in some shape, way or form?

Read more

New therapies – Niemann-Pick type C disease

Abstract: Niemann-Pick disease type C (NP-C) is an autosomal recessive disorder characterized by progressive neurological deterioration leading to premature death.

Read more